Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Society of You vs Spry

Society of You
Graded #274

Higher grade

vs+5.600000000000001
Spry
Graded #409

Lower grade

The verdict

Society of You takes it — 62.4/100 to 56.8/100.

Society of You grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Society of You is a US telehealth brand (Society Management Group) offering compounded GLP-1 weight-loss medication filled through named partner pharmacies (Emerald and Striker).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +15
39
54
Dose & formulationSociety of You +24
88
64
Clinical oversightSociety of You +20
75
55
Labs & monitoringEven
52
52
FulfillmentSociety of You +4
65
61
Contract termsEven
55
55
Society of You · left barSpry · right bar

The numbers

MetricSociety of YouSpry
WeighScore62.4/10056.8/100
GradeCC
Scorecard rank#274#409
Semaglutide$279/mo (promotional rate, compounded)$199/mo (starting dose, compounded)
Tirzepatide$425/mo (compounded)$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Society of You

Graded #274 · C

Strengths

  • Two named partner pharmacies disclosed (Emerald Pharmacy, Striker Pharmacy)
  • Injectable and oral tirzepatide plus semaglutide options
  • Discounted first-month introductory pricing

Where it loses points

  • Standard rates are high once the intro month ends ($279-$425/mo)
  • Service-area states are not published on the marketing site
  • Support details are not disclosed publicly
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard